Identification of a novel antiangiogenic agent; 4-(N-imidazol-2-ylmethyl)amino benzopyran analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 10, 2003, Pages 1661-1663

  Kim, Nakjeong ^b   Lee, Sunkyung ^a   Yi, Kyu Yang ^a   Yoo, Sung Eun ^a   Kim, Guncheol ^b   Lee, Chong Ock ^a   Park, Sung Hee ^a   Lee, Byung Ho ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 (N IMIDAZOL 2 YLMETHYL)AMINOBENZOPYRAN; ADENOSINE TRIPHOSPHATE; ANGIOGENESIS INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFECT; DRUG IDENTIFICATION; HUMAN; HUMAN CELL; ISCHEMIA; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUDE MOUSE; SIDE EFFECT; TUMOR GROWTH; XENOGRAFT;

MUS MUSCULUS;

EID: 0038702257     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00248-8     Document Type: Article

References (9)

1. Semenza G.L. Annu. Rev. Med. 54:2003;17.
2. Coghlan M.J., Carroll W.A., Gopalakrishnan M. J. Med. Chem. 44:2001;1627.
3. Rovnyak G.C., Ahmed S.Z., Ding C.Z., Dzwonczyk S., Ferrara F.N., Humphreys W.G., Grove G.J., Santafianos D., Atwal K.S., Baird A.J., McLaughlin L.G., Normandin D.E., Sleph P.G., Traeger S.C. J. Med. Chem. 40:1997;24.
4. Yoo S., Yi K.Y., Lee S., Suh J.K.N., Lee B., Seo H.W., Kim S.-O., Lee D.-H., Lim H., Shin H.S. J. Med. Chem. 44:2001;4207.
5. Sepp-Lorenzino L., Thomas K. Exp. Opin. Investig. Drugs. 11:2002;1447.
6. Liekens S., De Clercq E., Neyts J. Biochem. Pharmacol. 61:2001;253.
7. Ferreira C.G., Huisman C., Giaccone G. Clinical Reviews in Oncology and Hematology. 41:2002;57.
8. Hamby J.M., Showalter H.D. Pharmacol. Ther. 82:1999;169.
9. D'Alonzo A.J., Darbenzio R.B., Sewter J.C., Hess T.A., Grover G.J., Sleph P.G., Normandin D.E., Lodge N.J. Eur. J. Pharmacol. 294:1995;271.